Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126004712 | 12600471 | 2 | F | 20150928 | 20160728 | 20160727 | 20160728 | EXP | FR-PFIZER INC-2016355725 | PFIZER | 86.00 | YR | F | Y | 0.00000 | 20160728 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126004712 | 12600471 | 1 | PS | ALDACTONE | SPIRONOLACTONE | 1 | Oral | 25 MG, DAILY IN THE MORNING | Y | 12151 | 25 | MG | FILM-COATED TABLET | ||||||
| 126004712 | 12600471 | 2 | I | DIFFU K | POTASSIUM CHLORIDE | 1 | Oral | 2 DF, 3X/DAY | Y | 0 | 2 | DF | CAPSULE | TID | |||||
| 126004712 | 12600471 | 3 | I | PERINDOPRIL | PERINDOPRIL | 1 | Oral | 4 MG, 1X/DAY | Y | 0 | 4 | MG | QD | ||||||
| 126004712 | 12600471 | 4 | C | CORDARONE | AMIODARONE HYDROCHLORIDE | 1 | Oral | 200 MG, DAILY | 0 | 200 | MG | TABLET | |||||||
| 126004712 | 12600471 | 5 | C | LASILIX /00032601/ | FUROSEMIDE | 1 | Oral | 80 MG, 1X/DAY IN THE MORNING | 0 | 80 | MG | TABLET | QD | ||||||
| 126004712 | 12600471 | 6 | C | BISOPROLOL FUMARATE. | BISOPROLOL FUMARATE | 1 | Oral | 1.25 MG, DAILY | 0 | 1.25 | MG | ||||||||
| 126004712 | 12600471 | 7 | C | SERESTA | OXAZEPAM | 1 | Oral | 5 MG, 2X/DAY IN THE MORNING AT IN THE EVENING | 0 | 5 | MG | TABLET | BID | ||||||
| 126004712 | 12600471 | 8 | C | MODOPAR | BENSERAZIDE HYDROCHLORIDELEVODOPA | 1 | Oral | 2 DF, 2X/DAY IN THE MORNING AND IN THE EVENING | 0 | 2 | DF | CAPSULE | BID | ||||||
| 126004712 | 12600471 | 9 | C | SPECIAFOLDINE | FOLIC ACID | 1 | Oral | 0.4 MG, DAILY IN THE MORNING | 0 | .4 | MG | TABLET | |||||||
| 126004712 | 12600471 | 10 | C | KARDEGIC | ASPIRIN LYSINE | 1 | Oral | 75 MG, 1X/DAY | 0 | 75 | MG | POWDER FOR ORAL SOLUTION | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126004712 | 12600471 | 1 | Cardiac failure |
| 126004712 | 12600471 | 3 | Cardiac failure |
| 126004712 | 12600471 | 4 | Hypertensive heart disease |
| 126004712 | 12600471 | 6 | Cardiac failure |
| 126004712 | 12600471 | 8 | Tremor |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126004712 | 12600471 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126004712 | 12600471 | Acute kidney injury | |
| 126004712 | 12600471 | Drug interaction | |
| 126004712 | 12600471 | Hyperkalaemia | |
| 126004712 | 12600471 | Sinus node dysfunction |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126004712 | 12600471 | 1 | 201509 | 0 | ||
| 126004712 | 12600471 | 3 | 201509 | 0 |